Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1994
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
1997 3
2008 1
2014 1
2016 1
2018 1
2019 1
2021 1
2022 3
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer.
He L, Kang Q, Chan KI, Zhang Y, Zhong Z, Tan W. He L, et al. Front Immunol. 2023 Jan 19;13:1093990. doi: 10.3389/fimmu.2022.1093990. eCollection 2022. Front Immunol. 2023. PMID: 36776395 Free PMC article. Review.
They are involved in diverse pathophysiological processes, such as tumor invasion and metastasis, cardiovascular diseases, arthritis, periodontal disease, osteogenesis imperfecta, and diseases of the central nervous system. MMPs participate in the occurrence and dev …
They are involved in diverse pathophysiological processes, such as tumor invasion and metastasis, cardiovascular diseases, arthritis, period …
Osteogenesis Imperfecta/Ehlers-Danlos Overlap Syndrome and Neuroblastoma-Case Report and Review of Literature.
Morabito LA, Allegri AEM, Capra AP, Capasso M, Capra V, Garaventa A, Maghnie M, Briuglia S, Wasniewska MG. Morabito LA, et al. Genes (Basel). 2022 Mar 25;13(4):581. doi: 10.3390/genes13040581. Genes (Basel). 2022. PMID: 35456387 Free PMC article. Review.
Osteogenesis imperfecta/EhlersDanlos (OI/EDS) overlap syndrome is a recently described disorder of connective tissue, characterized by mutation of COL1A1 (17q21.33) or COL1A2 (7q21.3) genes, that are involved in alpha-1 and alpha-2 chains of type 1 collagen s
Osteogenesis imperfecta/EhlersDanlos (OI/EDS) overlap syndrome is a recently described disorder of connective tissue, characte
Advances in the Classification and Treatment of Osteogenesis Imperfecta.
Thomas IH, DiMeglio LA. Thomas IH, et al. Curr Osteoporos Rep. 2016 Feb;14(1):1-9. doi: 10.1007/s11914-016-0299-y. Curr Osteoporos Rep. 2016. PMID: 26861807 Review.
Osteogenesis imperfecta (OI) is a rare disorder of type 1 collagen with 13 currently identified types attributable to inherited abnormalities in type 1 collagen amount, structure, or processing. ...In addition to the skeletal phenotype, common a
Osteogenesis imperfecta (OI) is a rare disorder of type 1 collagen with 13 currently identified types attributab
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L. Folkestad L. Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Free article. Review.
Ostegenesis imperfecta (OI) is a hereditary disease of the connective tissue caused by mutations to, mainly, the genes that are involved in the biosynthesis of collagen type 1. ...The study included 39 patients with OI type I, and 39 healthy age and gender ma …
Ostegenesis imperfecta (OI) is a hereditary disease of the connective tissue caused by mutations to, mainly, the genes that are invol …
Hereditary dentin defects with systemic diseases.
Su T, Zhu Y, Wang X, Zhu Q, Duan X. Su T, et al. Oral Dis. 2023 Sep;29(6):2376-2393. doi: 10.1111/odi.14589. Epub 2023 Apr 24. Oral Dis. 2023. PMID: 37094075 Review.
RESULTS: Over 10 systemic diseases, including osteogenesis imperfecta, hypophosphatemic rickets, vitamin D-dependent rickets, familial tumoral calcinosis, Ehlers-Danlos syndrome, Schimke immuno-osseous dysplasia, hypophosphatasia, Elsahy-Waters syndrome, Singleton-M …
RESULTS: Over 10 systemic diseases, including osteogenesis imperfecta, hypophosphatemic rickets, vitamin D-dependent rickets, …
SURGICAL MANAGEMENT OF RETINAL DETACHMENT IN OSTEOGENESIS IMPERFECTA: CASE REPORT AND REVIEW OF THE LITERATURE.
Fleissig E, Barak A. Fleissig E, et al. Retin Cases Brief Rep. 2019 Winter;13(1):43-46. doi: 10.1097/ICB.0000000000000527. Retin Cases Brief Rep. 2019. PMID: 28085759 Review.
PURPOSE: To describe a case of scleral buckling in a patient with severe (Type III) osteogenesis imperfecta. METHODS: Single interventional case report of a 37-year-old woman, with clinically diagnosed osteogenesis imperfecta Type III, pr …
PURPOSE: To describe a case of scleral buckling in a patient with severe (Type III) osteogenesis imperfecta. METHODS: S …
Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.
Marini JC, Reich A, Smith SM. Marini JC, et al. Curr Opin Pediatr. 2014 Aug;26(4):500-7. doi: 10.1097/MOP.0000000000000117. Curr Opin Pediatr. 2014. PMID: 25007323 Free PMC article. Review.
PURPOSE OF REVIEW: Osteogenesis imperfecta or 'brittle bone disease' has mainly been considered a bone disorder caused by collagen mutations. ...Finally, absence of the type I collagen C-propeptidase bone morphogenetic protein 1 (BMP1) causes type XII …
PURPOSE OF REVIEW: Osteogenesis imperfecta or 'brittle bone disease' has mainly been considered a bone disorder caused by coll …
Prolidase-dependent regulation of collagen biosynthesis.
Surazynski A, Miltyk W, Palka J, Phang JM. Surazynski A, et al. Amino Acids. 2008 Nov;35(4):731-8. doi: 10.1007/s00726-008-0051-8. Epub 2008 Mar 5. Amino Acids. 2008. PMID: 18320291 Review.
Prolidase [EC.3.4.13.9] is a cytosolic imidodipeptidase, which specifically splits imidodipeptides with C-terminal proline or hydroxyproline. ...It is of great importance during wound healing, inflammation, aging, tissue fibrosis and possibly skeletal abnormalities seen in …
Prolidase [EC.3.4.13.9] is a cytosolic imidodipeptidase, which specifically splits imidodipeptides with C-terminal proline or hydroxy …
Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels.
Kuivaniemi H, Tromp G, Prockop DJ. Kuivaniemi H, et al. Hum Mutat. 1997;9(4):300-15. doi: 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9. Hum Mutat. 1997. PMID: 9101290 Review.
A majority (217 mutations; 78% of the total) of the mutations are single-base and either change the codon of a critical amino acid (63%), or lead to abnormal RNA splicing (13%). Most of the amino acid substitutions are those of a bulkier amino acid for the obligatory glyci …
A majority (217 mutations; 78% of the total) of the mutations are single-base and either change the codon of a critical amino acid (63%), or …
Hearing loss (in nonoperated ears) in relation to age in osteogenesis imperfecta type I.
Garretsen AJ, Cremers CW, Huygén PL. Garretsen AJ, et al. Ann Otol Rhinol Laryngol. 1997 Jul;106(7 Pt 1):575-82. doi: 10.1177/000348949710600709. Ann Otol Rhinol Laryngol. 1997. PMID: 9228859 Review.
Hearing loss was studied in relation to age in nonoperated ears in a group of 142 subjects with autosomal dominant osteogenesis imperfecta type I, which was compared to that in a random subsample of 70 subjects. ...
Hearing loss was studied in relation to age in nonoperated ears in a group of 142 subjects with autosomal dominant osteogenesis im
14 results